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Background and Objective: The development and
feasibility of a novel nanocrystalline yttria-stabilized-
zirconia (nc-YSZ) cranial implant has been recently
established. The purpose of what we now call “window to
the brain (WttB)” implant (or platform), is to improve
patient care by providing a technique for delivery and/or
collection of light into/from the brain, on demand, over
large areas, and on a chronically recurring basis without
the need for repeated craniotomies. WttB holds the
transformative potential for enhancing light-based
diagnosis and treatment of a wide variety of brain
pathologies including cerebral edema, traumatic brain
injury, stroke, glioma, and neurodegenerative diseases.
However, bacterial adhesion to the cranial implant is the
leading factor for biofilm formation (fouling), infection, and
treatment failure. Escherichia coli (E. coli), in particular,
is the most common isolate in gram-negative bacillary
meningitis after cranial surgery or trauma. The transpar-
ency of our WttB implant may provide a unique opportu-
nity for non-invasive treatment of bacterial infection under
the implant using medical lasers.
Study Design/Materials and Methods: A drop of a
diluted overnight culture of BL21-293 E. coli expressing
luciferase was seeded between the nc-YSZ implant and the
agar plate. Thiswas followed by immediate irradiationwith
selected laser. After each laser treatment the nc-YSZ was
removed, and cultures were incubated for 24 hours at 37 8C.
The study examined continuous wave (CW) and pulsed
wave (PW) modes of near-infrared (NIR) 810nm laser
wavelength with a power output ranging from 1 to 3W.
During irradiation, the temperature distribution of nc-YSZ
surface was monitored using an infrared thermal camera.
Relative luminescence unit (RLU) was used to evaluate the
viability of bacteria after the NIR laser treatment.
Results: Analysis of RLU suggests that the viability of
E. coli biofilm formation was reduced with NIR laser
treatment when compared to the control group (P< 0.01)
and loss of viability depends on both laser fluence and
operation mode (CW or PW). The results demonstrate
that while CW laser reduces the biofilm formation
more than PW laser with the same power, the higher
surface temperature of the implant generated by CW
laser limits its medical efficacy. In contrast, with the
right parameters, PW laser produces a more moderate
photothermal effect which can be equally effective at
controlling bacterial growth.
Conclusions: Our results show that E. coli biofilm
formation across the thickness of the nc-YSZ implant
can be disrupted using NIR laser treatment. The results of
this in vitro study suggest that using nc-YSZ as a cranial
implant in vivo may also allow for locally selective, non-
invasive, chronic treatment of bacterial layers (fouling)
that might form under cranial implants, without causing
adverse thermal damage to the underlying host tissue
when appropriate laser parameters are used. Lasers Surg.
Med. 48:782–789, 2016.  2016 Wiley Periodicals, Inc.
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INTRODUCTION
The fundamental aim of the window to the brain (WttB)
implant/platform is to improve patient care by providing a
technique for delivery and/or collection of light into/
from the brain, on demand, over large areas, and on
a chronically recurring basis without the need for
repeated craniotomies. Transparent nanocrystalline
yttria-stabilized-zirconia (nc-YSZ) provides both the trans-
parency and toughness required for enhancing the light-
based diagnosis and treatment of a wide variety of brain
pathologies including cerebral edema, traumatic brain
injury, stroke, glioma, and neurodegenerative diseases,
among many others. Using optical coherence tomography
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(OCT), we demonstrated the initial feasibility of nc-YSZ
cranial implants within the context of cortical imaging of
an acute murine model [1]. For optical clearing of the scalp
temporarily, our study on delivery techniques of optical
clearing agents (OCA) such as propylene glycol (PG)
showed that the combination of heated PG, microneedling
and vacuum pretreatments, and positive pressure post-
treatment significantly enhanced the perfusion of this
topically applied OCA [2].
Unfortunately, bacterial adhesion to cranial implant
biomaterials (fouling) is followed by colonization, biofilm
formation, infection and, eventually, implant failure [3].
Despite advances in sterilization and antiseptic techni-
ques, deep infection is themajor leading complication after
cranioplasty, with reported rates between 21% and
40% [4–7]. Infection might evolve due to contamination
during surgery, local infections elsewhere in the body, or
suppressed immune system [8]. Thus, bacterial adhesion
to the implant and biofilm formation may limit the use of
WttB for optical imaging and therapy, especially in
immunocompromised patients. In particular, Escherichia
coli (E. coli) is one of the most common isolates in gram-
negative bacillary meningitis after cranial surgery or
trauma in adults [3,9]. It has also been shown that E. coli
peritonitis causes increased blood-brain barrier perme-
ability [10]. Due to poor penetration of antimicrobial
agents to the cerebrospinal fluid and resistance of biofilms
to antimicrobial agents, the conventional treatment for
cranial implant infection is removal and replacement of the
implant, adding delays and cost to cranioplasties [11,12].
Sterilization of implant surfaces using lasers has been
suggested [13,14] and resulted in several promising
reports [15,16]. Previous data, however, demonstrates
that temperature increase of 10 8C induces tissue damage
in the bone [17–19] and denaturation of lipids and
proteins [20]. Therefore, it is critical to ensure that the
temperature change stays below this threshold for thermal
damage during laser application.
Genetically engineered bacteria that express luciferase,
from the American firefly, has been used in several models
to optically monitor bacterial number and viability in real
time [21]. Bioluminescence occurs when luciferase cata-
lyzes the formation of the luciferin excited state in the
presence of Mg2þ, ATP, and oxygen. Therefore, light can
only be produced from live and metabolically active cells,
which are able to generate ATP [22]. Validation of a non-
invasive, real-time imaging technology using biolumines-
cent E. coli has been demonstrated in the neutropenic
mouse thigh model of infection [23]. This demonstration
showed that the intensity of luminescence images is
proportional to the magnitude of the infection.
The transparency of the nc-YSZ implant provides us
with the unique opportunity to shine a near-infrared (NIR)
laser to treat the infected biomaterial locally and chroni-
cally, on-demand, without the need for removing the
implant. Although the use of lasers to reduce bacterial
growth in vitrowas previously reported [24–26], the use of
a transparent nc-YSZ implant for a non-invasive laser
treatment of implant fouling is entirely novel. The
objective of this in vitro study was to model bacterial
growth underneath the nc-YSZ implant (i.e., implant
fouling) and study the efficacy of distinct NIR laser
irradiation parameters to disrupt bacteria viability and
biofilm formation. The results from this in vitro model
provide a strategy to study properties of nc-YSZ transpar-
ent cranial implants prior to investigations in more
complex models such as in vivo animal studies.
MATERIALS AND METHODS
Implant Fabrication and Preparation
Transparent nc-YSZ (8mol.% of Yttria) cranial
implants were fabricated with current activated pressure
assisted densification (CAPAD), an emerging technique
that enables reduction of internal porosity to nanometric
dimensions, and thus, reduction of the optical scattering
that renders typical YSZ opaque [27]. Details of nc-YSZ
fabrication and optical characterization have been
reported previously [28,29], and %Transmittance mea-
sured with a Varian Cary 500 spectrophotometer
(350–3,300 nm) and Equinox 55 FTIR spectrometer
(3,300–13,000 nm) is provided in Figure 1. The room
temperature thermal conductivity (k) for nc-YSZ has
been reported previously as 2–2.45Wm1K1 [30], and
the specific heat (Cp) of YSZ (an intrinsic material
property which does not exhibit any significant dependence
on stabilizer content, phase composition or microstructure)
has been reported as 427 14Jkg1K1 [31]. The volumet-
ric density (r) of the nc-YSZ samples used in this study
was measured to be 6042kgm3, allowing for the
thermal diffusivity (a) of our samples to be calculated
as 7.75103–9.49 103 cm2 s1 (see footnote1). The
nc-YSZ samples used in this study were circular discs of
19.07mmdiameterand0.70mmthickness, and the average
surface roughness (Ra) was measured using atomic force
microscopy (AIST-NT) to be approximately 10nm. Prior to
each experiment, nc-YSZ samples were dry sterilized
(Germinator 500) at 250 8C for 10 seconds to remove all
pre-existing bacteria.
Bacteria Inoculation
For all experiments, genetically engineered BL21 E. coli
(CMC0014, Sigma–Aldrich, St. Louis, MO) phenotype that
emits bioluminescence was used. Briefly, BL21 cells were
transformed with P. Pyralis luciferase gene on pET28b(þ)
vector. The transformants were cultured in Lysogeny
Broth (LB) media supplemented with Kanamycin antibi-
otic (Kþ). Laser irradiation experiments were run on agar
plates containing Kþ and protein expression inducer
Isopropyl
b-D-1-thiogalactopyranoside (IPTG). Specifically, BL21
E. coli culture was grown overnight in a shaker at 37 8C
for 16 hours in the LB-Kþ until the OD600 reached 0.6–0.7.
1a¼ k/(r Cp) a¼ thermal diffusivity, k¼ thermal conductiv-
ity¼2–2.45Wm1K1, r¼density¼6042kgm3, Cp¼ specific
heat¼427Jkg1K1. a¼ (2–2.45Wm1K1)/(6,042kgm3  427
Jkg1K1)¼7.75103–9.49103 cm2 s1.
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One microliter of the overnight culture was diluted in
100mL of fresh LB-Kþ media. As shown in Figure 2, agar
plateswere placed on a heated pad set to body-temperature
in order to simulate in vivo conductivity and diffusivity of
heat. For each experiment, 0.5mL of the diluted bacteria
was seeded on agar and the nc-YSZ was placed on top. The
bacteria underlying nc-YSZwas treatedwith selected laser
parameters through the nc-YSZ. The nc-YSZ was then
removed from the culture and the plate was incubated for
24 hours at 37 8C.
Laser Device
Photo-irradiation was performed using an 810nm laser
(Vari-Lase) operated in continuous (CW) and pulse (PW)
modes. The laser beam was coupled into a 600mm optical
Fig. 1. (A) %Transmittance of nc-YSZ over the visible-IR spectral range. (B) Blowup of %
Transmittance of nc-YSZ over the vis-NIR spectral range, including the laser treatment
wavelength of 810nm. (C) Blowup of %Transmittance of nc-YSZ over the IR spectral range
measured by the infrared thermal camera. The black curve was measured with a Varian Cary 500
spectrophotometer (350–3,300nm) and the gray curve was measured with an Equinox 55 FTIR
spectrometer (3,300–13,000nm).
Fig. 2. Schematic diagram for the treatment of biofilm formation under nc-YSZ with NIR laser
irradiation.
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fiber to produce a 7mm diameter (1/e2) circular spot
with a Gaussian profile on the nc-YSZ. The variable
laser parameters were power (1–3W corresponding to
2.6–7.8Wcm2) and pulse rate (0.3–5Hz), and all laser
treatments were 20 seconds in duration. Each combination
of radiant exposure and frequencymodulationwas tested a
total of nine times. Control cultures were treated in an
identicalmanner to the irradiated cultures, except that the
laser was not switched on.
Temperature Measurements
During laser treatment, the temperature of the surface
of nc-YSZ was recorded with a non-contact infrared
thermal camera (A325sc, FLIR Systems Inc., Wilsonville,
OR) operating in video mode at 60 frames/s over the
spectral range of 7.5–13mm. Over this wavelength range,
the nc-YSZ implant was essentially opaque (Fig. 1c), and
thus the IR radiation measured by the camera was
primarily emitted by the upper surface of the implant,
and not originating from the underside of the implant in
contact with the bacteria. The video was post-processed
using ResearchIR software (FLIR ResearchIR4). Accord-
ing to specifications, the camera measures temperatures
with a precision of 50mK, has an accuracy of 2%, and a
viewing angle of 5–608.
Bioluminescence Imaging System
Following the 24 hours incubation, 100mL of luciferin
solution (13.4mg of D-Luciferin potassium salt/mL;
Research Products International Corp., Mt Prospect, IL)
was added at room temperature to evenly cover each
agar plate containing the irradiated bacteria (hereafter
referred to as “sample”) in preparation for bioluminescence
measurements. Luciferin diffuses through the cell mem-
brane where it reacts with the luciferase that is expressed
by the E. coli to produce oxyluciferin. The decay of
oxyluciferin produces a photon of light. Light emission of
the bioluminescent bacteria was measured using a Macro
Luminescence Dark Box (Stanford Photonics, Inc., Palo
Alto, CA) in darkness with 5 seconds exposure at 2MHz
rate. ImageJ software (National Institute of Health) was
used to quantify the light emission intensity at the
irradiated Regions of Interest (ROIs). The ROIs encom-
passed a circle equal to the beam spot size on the sample
(7mm diameter). The relative luminescence unit (RLU) in
the ROI was normalized with respect to the RLU outside
of the ROI for each sample. The imaging procedure,
acquisition parameters, and post-analysis were kept
constant for all measurements.
Statistical Analysis
ThedifferencebetweennormalizedRLUof control samples
and laser-irradiated samples was statistically evaluated
using analysis of variance for repeated measurements
(ANOVA). When appropriate, post hoc analyses were
performed with the Bonferroni’s multiple comparisons test.
ThompsonTau testwasused to remove outliers. All statistics
were calculated using GraphPad Prism 5.01 (GraphPad
Software, Inc., San Diego, CA). Changes were considered
statistically significant when the P-value was less than 0.05.
RESULTS
Figure 3 shows normalized RLU of biofilm after 24hours
and the average temperature (DT) of the upper surface of
the nc-YSZ at the end of the 20 seconds laser treatment
using CW laser with 1, 2, and 3W of power and 20 seconds
of exposure time to deliver a total of 20, 40, 60 J of energy,
respectively. The results show that the decrease in the
RLU value is statistically significant for all treated groups
compared to control (P< 0.05) and thatDT for theCW laser
powers above 1W is above 10 8C, which is considered the
critical threshold for thermal damage. When CW laser is
used, the reduction in biofilm formation seems to follow a
linear relationship with DT.
Figure 4 shows normalized relative luminescence unit
(RLU) of biofilm after 24hours and the average tempera-
ture (DT) of the upper surface of the nc-YSZ at the end of
the 20 seconds laser treatment using CW or PW laser with
3W of power. Treatment with all laser parameters except
for 0.5 and 0.3Hz leads to a significant reduction of E. coli
viability compared to the control group (P< 0.05). The
results indicate that the DT is above the 10 8C critical
temperature threshold for CW laser and all the PW laser
settings exceeding 200ms pulse duration and 1Hz, when
3W power is used.
Comparing bar #3, bar #5, bar #6, and bar #7 (frequency
of 5, 1, 0.5, and 0.3Hz, respectively) in Figure 4 indicates
that laser treatment with higher frequency results in
greater reduction in E. coli biofilm formation. Comparing
bar #4 and bar #5 (1Hz 400ms vs. 1Hz 200ms) indicates
that doubling the energy density per pulse and pulse
duration increases the temperature of the surface of
the implant by about 3 8C while it has negligible effect
on the reduction rate of E. coli biofilm formation.
Fig. 3. Normalized relative luminescence unit (RLU) of biofilm
after 24hours and the average temperature (DT) of the upper
surface of the nc-YSZ at the end of the 20 seconds laser treatment
using CW laser with 1, 2, and 3W of power to deliver a total of 20,
40, 60 J of energy, respectively. Each bar represents meanSEM
(n¼9 for each treatment). One-way ANOVA and Bonferroni’s
multiple comparison test P<0.05, P<0.01, P<0.001
relative to control.
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The results indicate that CW laser has the higher
reduction rate of E. coli biofilm formation compared to PW
laser at the same power (3W), but also causes a greater
increase in temperature. In contrast to the linear
relationship of temperature and reduction in biofilm
formation for CW laser (Fig. 3), there is no linear
relationship between the differences in temperature
change and the distinct variability of the bactericidal
effects of PW laser (Fig. 4).
DISCUSSION
WttB provides the transparency and toughness required
for clinically viable cranial implants for optical therapy
and imaging of the brain [1]. Zirconia surfaces have lower
bacteria adhesion compared to other implant materi-
als [32], however, infection due to implantitis is the most
significant risk factor associated with cranial implants
independent of the implant material [33]. In almost all
cases of cranial implant infection, it is recommended to
remove and later replace the implant to avoid intradural
propagation of the infection and the severe consequent
risk [11]. Therefore, new treatment techniques are
demanded as infections associated with cranial implants
lead to chronic complications [34].
In this study, we chose 810nm as our wavelength to
conduct the laser treatment of bacteria for several reasons.
Various NIR diode lasers and Nd:YAG lasers are com-
monly and successfully used in endodontics for disinfection
of almost all bacteria species. Diode lasers (l¼ 810nm)
have been used to effectively reduce the viability of biofilm
that adhered to zirconia dental implant surfaces. Stu-
binger et al. [35] studied the effect of diode (l¼ 810nm),
CO2 (l¼10,600nm), and Er:YAG laser (l¼ 2,940nm) on
surface properties of yttria-stabilized tetragonal zirconia
polycrystal (Y-TZP) implant surface using SEM, confocal
3Dwhite light microscopy (CWLM), and energy-dispersive
X-ray (EDX), and demonstrated that currently, diode
lasers seem to be the only laser systems offering surface
preservation and safety in the treatment of peri-implantitis
with zirconia, while longer wavelengths did not. On the
other hand, as shown in Figure 1b, the %Transmittance of
our nc-YSZ implant decreases for wavelengths lower than
810nm, and thus 810nm allowed for a higher fluence to
reach the bacteria through the implant, as well as surface
preservation of the implant.
Nussbaum et al. [36] have investigated the effects of CW
and frequency modulated 810nm laser on the growth of
E. coli and other bacterial species in culture previously,
and found that the effect is dependent upon several factors,
including bacterial species, modulation frequency, irradi-
ance, and radiant exposure. Interestingly, both promotion
and inhibition of bacterial growth rates were achieved by
modulation of the laser parameters. While CW laser
promoted E. coli growth regardless of radiant exposure
(up to 50J cm2,with 0.015Wcm2 irradiance), PWcaused
promotion and inhibition, depending on frequency and
radiant exposure, but the trend was less clear. In a follow
up study using CW 810nm laser, Nussbaum et al. [37]
found promotion of E. coli growth similar to their previous
study, but also inhibition ofE. coli growth when irradiance
was doubled (0.03Wcm2) and radiant exposure was
sufficiently high (>30 J cm2). In our study, we observed
inhibited E. coli growth for all laser parameters investi-
gated. It should be noted, however, that while the radiant
exposures reached in our study were similar to those
reached by Nussbaum et al., the irradiance used in our
study was substantially higher.
Our study further differs from these previous works due
to the presence of the nc-YSZ implant overlying the
bacteria during the laser treatment. As shown in
Figure 1b, the %Transmittance of the implant at 810nm
is 30%, and thus only 30% of photons reach the E. coli.
The remainder of the photons do not pass through the
implant, and are primarily absorbed resulting in heating of
the implant. Thus the observed reduction in biofilm
formation may be due to direct (optical transmission
through implant) or indirect (heating of implant) effects of
the laser on the E. coli, or a combination of both direct and
indirect effects.
To investigate these two simultaneous effects individu-
ally, we conducted an additional experiment where a 4mm
air gap was introduced between the bacteria and the
implant during laser treatment. This air gap served as a
thermal barrier to remove the indirect heating component,
and isolate the direct optical effect on the bacterial growth.
When the thermal component was removed, the statisti-
cally significant reduction in RLU of the biofilm is lost
(Fig. 5). While both laser treatments (CW, 3W and 5Hz,
3W, 200ms, bar #2 and bar #3, respectively) caused an
increase in normalized RLU relative to control, this
increase was not statistically significant (P¼ 0.4868).
This result demonstrates that the direct optical effect of
the laser on the E. coli, alone, cannot account for the
decrease in bacterial growth rate displayed in Figures 3
and 4.
Regarding the indirect effect of laser on the E. coli (i.e.,
heating of the implant), differences in the heat distribution
Fig. 4. Normalized relative luminescence unit (RLU) of biofilm
after 24hours and the average temperature (DT) of the upper
surface of the nc-YSZ at the end of the 20 seconds laser treatment
using 3W of power with CW and PW modes. Each bar represents
meanSEM (n¼9 for each treatment). One-way ANOVA
and Bonferroni’s multiple comparison test P<0.05, P<0.01,
P<0.001 relative to control.
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of the implant must be considered. As shown in Figure 1c,
the implant is essentially opaque in the wavelength range
measured by the thermal camera. Therefore, the temper-
atures reported in Figures 3 and 4 are only the tempera-
ture of the upper surface of the implant. Due to our
experimental design, with the implant in physical contact
with the bacteria during laser treatment (Fig. 2), it was not
possible tomeasure the temperature of the lower surface of
the implant during the treatments. To estimate this
temperature, we repeated the laser treatments on the
implant in isolation in air, andmeasured theDT of both the
upper and lower surfaces of the implant. We then adjusted
the DT of the upper surface of the implant reported in
Figures 3 and 4 by this ratio (Table 1). Laser treatments of
the agar plate in isolation resulted in negligible tempera-
ture increase of the agar (data not shown), and thus the
estimated temperature of the lower surface of the implant
shown in Table 1 can be treated as an approximate
temperature experienced by the E. coli in the laser
treatments from Figures 3 and 4.
Although there have been several in vivo and in vitro
reports demonstrating the bactericidal effect of medical
lasers on various strains, the underlying mechanisms of
photochemical or/and photothermal effects remain contro-
versial. Lee and Kaletunc¸ [38] demonstrated that heating
of E. coli from 55 to 70 8C for 60 seconds decreases the
viability significantly due to enthalpy change and irre-
versible damage to ribosomal subunits. Using the temper-
ature range of 50–70 8C and comparing temperature
increase by CW high-power NIR laser (18–81Wcm2)
andwater bath,Hibst et al. [39] showed that inactivation of
E. coli suspension is mainly driven by a thermal process.
However, the estimated temperatures reached by the
E. coli in our study (see Table 1) is much lower than the
temperatures in these reports, and thus it is unlikely that
the heating of the implant alone is responsible for the
decrease in bacterial growth rate displayed in Figures 3
and 4.
As neither a direct optical effect (Fig. 5), nor an indirect
thermal effect (Table 1) with the fluences and estimated
temperatures reached in our study are alone sufficient to
explain the observed inhibition in E. coli growth rate, it is
possible that the combination of these effects is responsi-
ble. Lubart et al. [40] has previously suggested reactive
oxygen species (ROS) generation as a mechanism for
phototoxic effect ofNIR light, whileNandakumar et al. [41]
have reported that the bactericidal effect of laser is due to a
reduction in ATP production which could in turn be due to
damage of bacterial metabolic processes such as cellular
respiration. While our results in Figure 5 showed that the
isolated direct optical effect of the laser used in our study
did not cause inhibition of the E. coli growth rate, perhaps
the increased temperature of theE. coli, due to the indirect
effect of the laser heating the implant, increases the
susceptibility of the bacteria to these optical damage
mechanisms. This possible explanation is speculative, and
will require further study to determine the effect of E. coli
temperature on the effectiveness of optical bactericidal
treatments.
Further studies are essential to realize the potential of
using lasers to reduce the formation of bacterial biofilm
under theWttB in vivo due to differences in geometry, and
optical and thermal properties of an in vivo model in
comparison with the in vitromodel used in this study. For
example, one of the differences of an in vivo model is that
the bacterial biofilm will have lower local temperatures
than our in vitromodel, due to the presence of corticospinal
Fig. 5. Normalized relative luminescence unit (RLU) of biofilm
24hours after 20 seconds laser treatment using 3W of power with
CWandPWmodes, with 4mmair gap between nc-YSZ andE. coli.
Each bar represents meanSEM (n¼3 for each treatment).
One-way ANOVA and Bonferroni’s multiple comparison test
P<0.05, P<0.01, P<0.001 relative to control.
TABLE 1. Estimated DT (8C) of the Lower Surface of the Implant at the End of the 20-Second Laser Treatments
Measured DT (8C) of
upper surface of implant
Measured ratio of DT (8C) of upper
surface to DT (8C) of lower surface
of implant
Estimated DT (8C) of
lower surface of implant
CW, 1W 5.27 2.88 1.83
CW, 2W 11.79 2.69 4.38
CW, 3W 18.85 2.64 7.14
5Hz, 3W, 200ms 16.55 2.62 6.33
1Hz, 3W, 400ms 12.62 2.74 4.60
1Hz, 3W, 200ms 8.93 3.00 2.98
0.5Hz, 3W, 200ms 4.17 3.11 1.34
0.3Hz, 3W, 200ms 2.06 2.83 0.73
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fluid (CSF) that can act as a thermal barrier to the brain.
Moreover, the distance between the brain and the inner
surface of the skull mapped by Fournier et al. [42] ranges
from 0.4 to 6.7mm. Therefore, depending on the actual
location of the implant, this distance has to be considered
in planning treatment. In addition, low-level laser therapy
(LLLT) using 810nm lasers has been shown to signifi-
cantly improve the neurobehavioral performance of mice
after closed head traumatic brain injury (TBI) [43].
Therefore, with careful choice of 810nm laser parameters,
treatment of biofilm formation can be performed along
with LLLT treatment of TBI. Finally, although the
estimated temperature reached by the bacteria underlying
the implant is below the critical threshold of 10 8C, the
temperature of the upper surface of the implant was
unacceptably high for several of the laser parameters
investigated in this study. Further studies will be
needed to investigate methods of mitigating this high
temperature during laser treatment, such as cryogenic
cooling methods [44].
In conclusion, our results show that E. coli biofilm
formation across the thickness of the nc-YSZ implant
can be disrupted using NIR laser treatment. The results
of this in vitro study suggest that using nc-YSZ as a
cranial implant in vivo may also allow for local, non-
invasive, chronic treatment of the formation of biofilm
on the inner surface of the cranial implant, without
inducing thermal damage to the underlying host tissue,
when appropriate laser parameters are used. Further
in vivo studies are necessary to investigate the efficacy
of biofilm inhibition and lack of thermal damage to
peri-implant tissue in situ.
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